COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 2269: Articles 22681-22690  | Next

The impact of COVID-19 infection on maternal and reproductive health care services in governmental health institutions of Dessie town, North-East Ethiopia, 2020 G.C.
Assefa, K. T., Gashu, A. W., Mulualem, T. D.
10.1101/2020.09.20.20198259 — Posted: 2020-09-23
Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: A systematic review and meta-analysis
PATANAVANICH, R., GLANTZ, S. A.
10.1101/2020.09.22.20199802 — Posted: 2020-09-23
Knowledge, Attitude and Practice towards COVID-19 among people in Bangladesh during the pandemic: a cross-sectional study.
Rabbani, M. G., Akter, O., Hasan, M. Z., Samad, N., Mahmood, S. S., Joarder, T.
10.1101/2020.09.22.20198275 — Posted: 2020-09-23
Exponential distribution of large excess death rates in Europe during the COVID-19 outbreak in the spring of 2020
Martin-Olalla, J. M.
10.1101/2020.09.20.20198283 — Posted: 2020-09-23
Empirical transmission advantage of the D614G mutant strain of SARS-CoV-2
Leung, K., Pei, Y., Leung, G. M., Lam, T. T. Y., Wu, J. T.
10.1101/2020.09.22.20199810 — Posted: 2020-09-23
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
Linares, M., Perez Tanoira, R., Romanyk, J., Perez Garcia, F., Gomez-Herruz, P., Arroyo, T., Cuadros, J.
10.1101/2020.09.20.20198192 — Posted: 2020-09-23
Nature and dimensions of the cytokine storm and its attenuation by convalescent plasma in severe COVID-19
Bandopadhyay, P., D'Rozario, R., Lahiri, A., Sarif, J., Ray, Y., Paul, S. R., Roy, R., Maiti, R., Chaudhuri, K., Bagchi, S., Maiti, A., Parwez, M. M., Sharma Sarkar, B., Roy, D., Chakraborty, R., Vasudevan, J. S., Sharma, S., Biswas, D., Maiti, C., Saha, B., Bhattacharya, P., Pandey, R., Chatterjee, S., Paul, S., Ganguly, D.
10.1101/2020.09.21.20199109 — Posted: 2020-09-23
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
Hashem, A. M., Algaissi, A., Almahboub, S. A., Alfaleh, M. A., Abujamel, T. S., Alamri, S. S., Alluhaybi, K. A., Hobani, H. I., AlHarbi, R. H., Alsulaiman, R. M., ElAssouli, M.-Z., Hala, S., Alharbi, N. K., Alhabbab, R. Y., AlSaieedi, A. A., Abdulaal, W. H., Bukhari, A., AL-Somali, A. A., Alofi, F. S., Khogeer, A. A., Pain, A., Alkayyal, A. A., Almontashiri, N. A., Mahmoud, A. B., Li, X.
10.1101/2020.09.21.20198309 — Posted: 2020-09-23
Norwich COVID-19 Testing Initiative: feasibility project evaluation
Berger Gillam, T., Cole, J., Gharbi, K., Hitchcock, M., Edwards, D., Brabbs, T., Lipscombe, J., Davidson, R., Rushworth, S. A., Steel, N.
10.1101/2020.09.22.20199455 — Posted: 2020-09-23 Discussion: Onsite
Challenges and opportunities of the COVID-19 pandemic for perinatal mental health care: a mixed methods study of mental health care staff
Wilson, C. A., Dalton-Locke, C. A., Johnson, S., Simpson, A., Oram, S., Howard, L. M.
10.1101/2020.09.23.20199927 — Posted: 2020-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).